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Cardiac hypertrophy, whether pathological or physi-
ological, induces a variety of additional morphologi-
cal and physiological changes in the heart, including
altered contractility and hemodynamics. Events exac-
erbating these changes are documented during later
stages of hypertrophy (usually termed pathological
hypertrophy). Few studies document the morpho-
logical and physiological changes during early
physiological hypertrophy. We define acute cardiac
remodeling events in response to transverse aortic
constriction (TAC), including temporal changes in hy-
pertrophy, collagen deposition, capillary density, and
the cell populations responsible for these changes.
Cardiac hypertrophy induced by TAC in mice was
detected 2 days after surgery (as measured by heart
weight, myocyte width, and wall thickness) and
peaked by day 7. Picrosirius staining revealed in-
creased collagen deposition 7 days after TAC; immu-
nostaining and flow cytometry indicated a concurrent
increase in fibroblasts. The findings correlated with
angiogenesis in TAC hearts; a decrease in capillary
density was observed at day 2, with recovery to sham-
surgery levels by day 7. Increased pericyte levels,
which were observed 2 days after TAC, may mediate
this angiogenic transition. Gene expression suggests
a coordinated response in growth, extracellular ma-
trix, and angiogenic factors to mediate the observed
morphological changes. Our data demonstrate that
morphological changes in response to cardiovascu-
lar injury occur rapidly, and the present findings
allow correlation of specific events that facilitate
these changes. (Am J Pathol 2012, 181:1226–1235; http://
dx.doi.org/10.1016/j.ajpath.2012.06.015)
1226The process of cardiac remodeling is responsible for
changes in cardiac morphology and function. Left ven-
tricular hypertrophy, which is observed in response to a
variety of pathophysiological signals, is a typical re-
sponse to pressure overload or any disease state that
increases cardiac wall stress and marks an adaptive
response to compensate to the unfavorable conditions.
Both mechanical and chemical stressors induce cardiac
remodeling, and over time the adaptive response con-
cedes to cardiac dilatation and the ensuing remodeling
process becomes maladaptive, leading to dysfunction,1
possibly as a result of enhanced catecholamine chemical
signaling by monoamine oxidases.2 Factors associated
with cardiac remodeling include myocyte hypertrophy,
increased extracellular matrix (ECM) deposition, and ab-
normalities of the coronary vasculature.3,4 The latter two
conditions often combine to create perivascular fibrosis,
and previous studies have demonstrated that reducing
myocardial fibrosis improves coronary hemodynamics.5
In addition, proliferation of nonmyocyte constituents (ie, fi-
broblasts, endothelial cells, immune cells, and smooth mus-
cle cells) encourages disorganized tissue heterogeneity,4
which is initially adaptive but subsequent overcompensa-
tion induces pathological cardiac remodeling.6
Two principal elements of pathological hypertrophic
remodeling that lead to malfunction are accumulation of
collagen and vascular remodeling.7 An increase in colla-
gen deposition stiffens the heart, resulting in systolic and
diastolic dysfunction,8 whereas insufficient angiogenesis
deprives the hypertrophic myocardium of oxygenation
because of low capillary density.9–11 Numerous studies
have attempted to alter these remodeling processes, with
varying success. Some authors have identified a relation-
ship between the degree of hypertrophy and prognosis:
higher survival rates were observed in patients treated
before left ventricular end systolic diameter reaches 40
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tion. Others have succeeded in correlating markers of
fibrosis with left ventricular hypertrophy and clinical heart
failure,13,14 indicating that the combination of hypertro-
phy and fibrosis results in cardiac dysfunction. In addi-
tion, it has been shown that treatment to increase capil-
lary density after a pathological insult is accompanied by
improved cardiac function, even if delayed treatment is
unable to decrease myocardial infarct size,15 suggesting
that capillary density may be more of a determining factor
than is tissue remodeling.
One overlooked aspect is the time course within which
these changes take place after pathological insult and
their progression in relation to each other. Mainly, studies
have investigated only later time points (day 7 and later),
when advanced stages of remodeling, adaption, and pa-
thology have already manifested in the heart.16 Limited
studies examining early responses to pathology have
uncovered important, cell-specific acute responses,17
but additional research is needed for a better under-
standing of the immediate response by the heart to injury.
In the present study, we analyzed the acute morpholog-
ical response within the first week after pathological car-
diac insult, to determine the early progression of cardiac
remodeling and correlate these remodeling events to bet-
ter understand the complex coordination and how it re-
lates to cardiac function. Here, we illustrate immediate
changes in cardiac hypertrophy, angiogenesis, fibrosis,
and alterations in the cell populations contributing to
these events. We also propose possible gene-specific
changes that may guide these morphological changes.
Materials and Methods
Animal Model of Pressure Overload
Hypertrophy
Transverse aortic constriction (TAC) was performed in
12-week-old male C57/BL6 mice, as described previ-
ously.18 Mice were anesthetized under 3% isoflurane via
intubation, the chest was opened, the aortic arch was
visualized, and 6–0 silk suture was passed under the
arch between the innominate and left common carotid
arteries. The suture was secured around both the aorta
and a 28-gauge needle, the needle was removed, the
chest was closed, and the mouse was extubated. Sham-
surgery mice underwent an identical procedure except
for the aortic ligation. Mice were provided buprenorphine
via intraperitoneal injection before recovery. Echocardio-
graphic analysis using a Vevo2100 digital imaging sys-
tem (VisualSonics, Toronto, ON, Canada) was performed
under 1% isoflurane at indicated time points (0, 2, 7, 14,
and 28 days), with mid ventricle M and B mode measure-
ments acquired in the parasternal short-axis view at the
level of the papillary muscles. In addition, echocardio-
graphic analysis and blood pressure measurements were
taken before surgery in all animals, to ensure an identical
baseline. Adequate levels of anesthesia were monitored by
toe pinch, and euthanasia was administered via cervical
dislocation under 5% isoflurane. Experiments were ap-proved by the Institutional Animal Care and Use Committee
(Scott & White Hospital and Texas A&M Health Science
Center) and conform to the Guide for the Care and Use of
Laboratory Animals (2011, 8th edition).
Transmission Electron Microscopy
Hearts (n  4) were removed at indicated time points
(2, 7, and 28 days) and were flushed in ice-cold PBS. The
mid left ventricular free wall and septum were isolated in
4% buffered glutaraldehyde and sectioned into 1-mm
blocks. After the initial fixation, samples were postfixed in
OsO4 with 2% tannic acid and then were dehydrated,
embedded, and sectioned as described previously.19
Samples were stained with uranyl acetate and lead hy-
droxide, and at least four separate grids were imaged for
each block with a JEOL 200CX transmission electron
microscope at 180 kV (JEOL, Tokyo, Japan). Low-mag-
nification imaging was followed by high-magnification im-
aging, and representative images were acquired.
Collagen Analysis
Picrosirius-Fast Green staining was modified from a pre-
vious protocol.20 Briefly, heart sections (10 m) were
fixed in 4% paraformaldehyde, stained in a solution of
0.1% Fast Green (Acros; Thermo Fisher Scientific, Pitts-
burgh, PA) and Sirius Red 0.1% in saturated picric acid
(Electron Microscopy Sciences, Hatfield, PA) and im-
aged at 20 magnification using a Nikon Eclipse TS100
inverted microscope with a Digital Sight DS-2Mv camera
and NIS-Elements software version 3.20. Images (6 per
animal) of mid left ventricle and septum were analyzed
using ImageJ software version 1.46 (NIH, Bethesda, MD).
The ratio of collagen to total tissue area was calculated.
Immunofluorescent Imaging
Frozen heart sections (10 m thick) were fixed and im-
munostained with rat anti-CD31 antibody (BD Pharmin-
gen, San Diego, CA), anti-3G5 antibody isolated from a
mouse B-lymphocyte hybridoma cell line (CRL-1814;
ATCC, Manassas, VA), and a fibroblast-specific rabbit
polyclonal antibody (1611) that was described in a pre-
vious report from our laboratory.21,22 Sections (6 per
animal) from the mid left ventricle and septum were coun-
terstained with DAPI and phalloidin and then were sequen-
tially imaged under a TCS SP5 white light laser confocal
microscope (Leica Microsystems, Wetzlar, Germany) at
40 and20 magnification. ImageJ software was used for
quantitative analysis, and total antibody staining was nor-
malized to DAPI or phalloidin.
Flow Cytometry
Whole hearts from TAC and sham surgery (n  4 each)
were prepared at indicated time points (0, 3, 7, and 14
days), as described previously.23 Briefly, hearts were
digested to single-cell suspensions with collagenase and
then were labeled with the following antibodies conju-
1228 Souders et al
AJP October 2012, Vol. 181, No. 10gated to Qdot nanocrystals (Life Technologies-Invitro-
gen, Carlsbad, CA), according to the manufacturer’s pro-
tocol: DDR2 (Santa Cruz Biotechnology, Santa Cruz, CA)
for fibroblasts, -myosin heavy chain (Abcam, Cam-
bridge, MA) for myocytes, CD31 (Zymed Laboratories,
South San Francisco, CA) for endothelial cells, and
-smooth muscle actin (R&D Systems, Minneapolis, MN)
for vascular smooth muscle cells. An equal number of
cells (20,000 events) for each sample were processed
using an Epics XL fluorescence-activated cell sorting
system (Beckman Coulter, Brea, CA) and were analyzed
using the associated Expo 32 software.
Real-Time PCR
Total RNA was extracted at indicated time points (0, 2,
and 7 days) from septa and left mid-ventricular regions of
TAC and sham-surgery hearts (n  4 each) using an
RNeasy Plus mini kit (Qiagen, Valencia, CA) according to
the manufacturer’s protocol. Isolated RNA was quantified
and converted to cDNA with an SABiosciences RT2 first-
strand kit (Qiagen), which was then quantified via quan-
titative real-time PCR using a StepOnePlus thermocycler
(Life Technologies-Applied Biosystems, Foster City, CA).
Primer sequences are available upon request.
Statistical Analysis
Echocardiographic, physiological, and immunofluores-
cent data were analyzed for significance using Student’s
t-test or an analysis of variance test with a Mann-Whitney
test. All analyses were performed using Microsoft Excel
version 12.3.3 and GraphPad Prism software version 4
(GraphPad Software, La Jolla, CA). Significance was set
at P  0.05.
Results
Early Cardiac Growth in TAC Mice
Hearts were examined for gross morphological changes
at early (day 2) and late time points (days 7, 14, and 28)
after induction of pressure overload by TAC surgery. All
animals had similar baseline measurements of cardiac
function and blood pressure. Survival rates after TAC
were approximately 70% at 28 days after surgery, in
accord with findings of similar studies from our laboratory
and from others.18 Echocardiographic analysis revealed
a significant increase in relative wall thickness just 48
hours after TAC surgery, which persisted through day 28
(Figure 1A). The ratio of heart weight to body weight also
revealed significant cardiac growth in TAC hearts by day
2, and this increased further until by day 7 growth peaked
and was maintained through day 28 (Figure 1B). To de-
termine the extent of myocyte hypertrophy during this
early growth period, myocyte width was measured in
F-actin-stained cross-sections (Figure 1C). Cardiac
growth 2 days after TAC cannot be attributed to myocyte
growth, because no significant change in myocyte width
was measured; however, a significant increase was ob-served at 7 days after TAC, indicating that myocyte hy-
pertrophy is a contributing factor to the increase in heart
weight and wall thickness observed by day 7. Taken
together, these data indicate that cardiac growth in re-
sponse to acute pressure overload is fully realized by day
7 after surgery.
Examination of cardiac function revealed a lower ejec-
tion fraction observed by day 2 and a significant de-
crease in day 28 TAC hearts (Figure 1D). A decrease in
cardiac function (ejection fraction) 28 days after TAC
indicates that the hypertrophy observed here progresses
into pathological decompensated cardiac hypertrophy. In
addition, a lower (albeit not significantly lower) ejection frac-
tion observed 2 days after TAC illustrates the importance of
acute cardiac remodeling in response to pathological insult
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Figure 1. Induction of pressure overload cardiac hypertrophy. Left ventric-
ular wall thickness was increased 2 days after transverse aortic constriction
(TAC) and was fully realized by day 7 (A), as measured by echocardiography
and heart weight (B), normalized to body weight. Measurement of myocyte
width indicated significant myocyte hypertrophy present 7 days after TAC
(C). In addition, a trend in lower ejection fraction at day 2 and 28 after TAC
was observed (D), implying impaired cardiac function at the acute and
chronic stages of cardiac hypertrophy. *P  0.05 TAC versus sham surgery at
the same time point; **P  0.05 TAC day 2 versus TAC at other time points.
n  6.to quickly recover normal cardiac function and maintain
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that occur within the first week after induction of cardiac
stress, we also investigated themorphological changes that
occur during this early time period.
Changes in Collagen Deposition in TAC Hearts
In the normal murine myocardium, collagen accounts for
very little of the overall tissue, which provides the malle-
ability that the heart requires.24,25 Approximately 3% of
total cardiac tissue was composed of collagen in sham-
surgery mice, as indicated by Picrosirius-Fast Green
staining (Figure 2, A and C) and quantification (Figure
2E). Similar levels were measured in day 2 TAC hearts,
indicating that collagen deposition is not an immediate
physiological reaction to pressure overload (Figure 2, B
and E). Conversely, a significant increase in collagen
deposition was observed in day 7 TAC hearts (Figure 2,
Figure 2. Picrosirius-Fast Green staining revealed a significant increase in
collagen deposition 7 days after TAC. Left ventricular and septal regions
contained basal levels of collagen in day 2 sham-surgery (A) and TAC (B)
hearts and in day 7 sham-surgery (C) hearts, whereas a significant increase
in fibrosis was observed in day 7 TAC hearts (D). E: Collagen measure-
ments were quantified as the ratio of collagen to protein. *P  0.05. n 
4. Scale bar  25 m.D and E), and interstitial fibrosis was evident along withdispersed focal fibrosis throughout the left ventricle and
interventricular septum.
Transmission electron microscopy was performed on
day 2 and day 7 sham-surgery and TAC hearts and
demonstrated a qualitative increase in the amount of
collagen and fibroblasts present in TAC hearts, com-
pared with sham-surgery controls (Figure 3). We also
qualitatively observed dramatic increases in the mito-
chondria in myocytes in TAC hearts at both time points.
Furthermore, in the TAC samples, the fibroblasts appeared
to be more active, with abundant rough endoplasmic retic-
ulum and enlarged Golgi apparatus, indicating high levels
of secretion. These data corroborated increased collagen
deposition and increased presence of secreted growth fac-
tors and cytokines in the TAC hearts.
Given previous studies uncovering a strong functional
link between ECM and vascular remodeling, we next
examined the course of angiogenesis after TAC surgery.
Figure 3. Increased ECM deposition and myocyte hypertrophy in TAC
hearts. Transmission electron microscopic images of left ventricular regions
in day 2 sham-surgery (A and C) and TAC (B and D) hearts and in day 7
sham-surgery (E and G) hearts revealed similar levels of dense ECM, whereas
a significant increase in ECM deposition was observed in day 7 TAC hearts (F
and H). Scale bar  2 m.
-regulat
(green)
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After TAC
For long-term survival of the hypertrophic heart, in-
creased vasculature must accompany the myocardial
expansion, to maintain tissue health.26 However, the early
vascular changes in response to pathological insult are
poorly understood. Immunostaining and subsequent
quantification (Figure 4) of the endothelial cell marker
CD31 revealed a significant decrease in capillary density
just 48 hours after TAC, which returned to sham-surgery
levels by day 7 (Figure 4). These data indicate that the
first stage of angiogenesis, destabilization of the existing
vasculature,27 occurs within 48 hours after induction of
hypertrophy and that the ensuing capillary growth takes
place in the days that follow, a time period that also
correlates with the observed increase in ECM deposition
(Figures 2 and 3).
Pericytes are involved in vascular remodeling after in-
jury in the heart,28 and their presence represents the end
of a window of vascular plasticity.29 We therefore exam-
ined the heart for pericytes during the early remodeling
process in response to TAC. A correlation with vascular
Figure 4. Immunofluorescent staining suggests alterations in cell populatio
sham-surgery (A–D) and TAC (E-H) and day 7 sham-surgery (I-L) and TAC
(Q) identified a significant decrease in capillary density in day 2 TAC hearts,
The fibroblast-specific marker 1611 demonstrated an increase in the fibrobla
H, L, and P) suggest that localization of cells was altered during the early r
day 2 sham-surgery and TAC hearts and in day 7 sham-surgery hearts were
7 days after TAC localized near capillary beds, suggesting a shift from pericyte
days 2 and 7 after TAC. In merged images, F-actin was stained by phalloidinremodeling was observed, with a significant increase inpericyte association with the vasculature 2 days after
TAC, which returned to sham-surgery levels by 7 days
(Figure 4). Although previous research using a myocar-
dial infarction model found that pericytes were involved in
long-term remodeling,28 the correlation observed here
suggests that pericytes play a role during the acute, early
destabilization process and/or immediate reformation of
the coronary vasculature in response to injury. Indeed,
recent studies suggest that pericytes are attempting to
stabilize vessels during the destabilization process,30
and it may be this balance that facilitates early capillary
growth. In addition, great vessels lacked pericyte asso-
ciation only in day 7 TAC hearts (Figure 4), further indi-
cating that large-scale vascular plasticity is present at
this time point in TAC animals, but not in the earlier day 2
TAC or sham-surgery animals.
The cardiac fibroblast is another cell that has been
identified as an important angiogenic potentiator.31,32
Immunostaining with the fibroblast-specific antibody
161121,22 revealed a close association of fibroblasts with
the microvasculature and myocardium under all experi-
mental conditions (Figure 4). However, quantification re-
vealed a significant up-regulation of the fibroblast popu-
vasculature in the hypertrophic heart. Immunofluorescent imaging of day 2
eart sections. CD31 staining (A, E, I, and M) and subsequent quantification
as accompanied by an increase in 3G5-labeled pericytes (B, F, J, N, and R).
opulation in day 7 TAC hearts (C, G, K, O, and S). The merged images (D,
ng process. Interestingly, pericytes localized near great vessels (arrows) in
sent in day 7 TAC samples. In addition, the increased fibroblast population
ed, early vascular regression to fibroblast-mediated capillary growth between
; nuclei were stained by DAPI (blue). Scale bar  100 m; n  4; *P  0.05.ns and
(M-P) h
which w
st cell p
emodeli
not prelation 7 days after TAC, which was not observed at the
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with 1611 was confirmed by staining with anti-vimentin
and anti-DDR2 antibodies (data not shown). As ex-
pected, this rise in the fibroblast population is concomi-
tant with fibrosis (Figure 2), but it may also be critical to
the angiogenic process in terms of stimulating revascu-
larization of the tissue after the observed early capillary
regression.
Cell Proliferation is Altered After Pressure
Overload
Given the extensive changes in cardiac cell populations,
we analyzed cell proliferation to further infer growth rate
and cell origin. In response to injury, new nonmyocyte
cells arise within the heart via recruitment of circulating
progenitors (fibrocytes), proliferation of resident cells, or
differentiation of other cell types.33,34 To determine the
amount of resident cardiac cell proliferation and growth in
response to TAC, we analyzed phosphorylated histone
H3 (p-histone H3) expression at 2, 7, and 28 days after
surgery (Figure 5, A–F). Although significant proliferation
and/or growth was observed in the total cardiac cell
population at day 2 in TAC hearts, compared with sham-
surgery counterparts, a further increase was observed in
day 7 TAC hearts (Figure 5G). In addition, the proportion
of p-histone H3-positive cells shifted from a 1:1 ratio of
myocytes to nonmyocytes to 1:3 by day 7 after TAC,
indicating that the increased proliferative rates are due
mainly to nonmyocyte populations. Interestingly, both to-
tal proliferating cells and the myocyte/nonmyocyte ratio
returned to sham-surgery levels by day 28 (Figure 5G).
Changes in Cardiac Cell Populations After TAC
To quantitatively analyze the changes in specific cell
populations, we used flow cytometry to measure cell pop-
ulations in TAC and sham-surgery animals at 3, 7, and 14
days after surgery. In accord with our immunostaining
findings, the fibroblast population does not increase until
7 days after TAC, at which point it remains elevated
through day 14 (Figure 6). Although it appears that the
myocyte population increases, absolute quantities do not
actually change, and it is only the percentage that de-
creases in response to the profound increase in fibro-
blasts. Also correlating with imaging data is the signifi-
cant decrease in the endothelial cell population at acute
time points (day 2) in response to TAC; this population
recovers by day 7 and remains so through day 14 (Figure
6). These data suggest that altered endothelial cell and
possibly fibroblast populations contribute to the angio-
genic stimulation indicated by early vascular regression
followed by vascular regrowth. Interestingly, the unla-
beled cell population is increased at the early time point,
possibly representing the increase in pericytes observed
with immunostaining. However, a further increase in un-
labeled cells was present at days 7 and 14, which may
indicate undifferentiated infiltrating progenitor cells.Figure 5. Cell proliferation and growth are induced by pressure overload.
Cell growth and proliferation were identified by p-histone H3 staining in
left ventricular and septal walls of day 2 sham-surgery (A) and TAC (B)
hearts, day 7 sham-surgery (C) and TAC (D) hearts, and day 28 sham-
surgery (E) and TAC (F) hearts. Quantification of positive nuclei demon-
strated a significant increase in proliferation after 2 days in TAC hearts,
which was further augmented by day 7 and then returned back to sham-
surgery levels by day 28 (G). Although a significant increase in nonmyo-
cyte proliferating cells is present in both day 2 and day 7 TAC mice, no
significant number of growing myocytes was present until day 7 in TAC
mice, after which numbers returned to sham-surgery levels by day 28 (E).
In addition, day 7 TAC hearts had significantly more nonmyocyte prolif-
erating cells, compared with day 2 or 28 TAC mice, and consequently had
significantly more proliferating nonmyocytes than growing myocytes (E),
indicating that the increased proliferative rate in day 7 TAC mice is due
mainly to expanding of resident nonmyocyte populations. F-actin was
stained by phalloidin (green); nuclei were stained by DAPI (blue) and
p-histone-positive nuclei were stained pink. *P  0.05 in TAC versus sham
surgery at the same time point; **P  0.05 in TAC day 7 versus TAC at
other time points; ***P  0.05 in myocyte versus nonmyocyte populations.
n  4. Scale bar  50 m.
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To examine possible mechanisms responsible for the
observed morphological changes, we measured the
expression of 95 genes, using real-time PCR. Genes
were grouped into the following categories: cardiac
hypertrophy markers, angiogenesis, growth versus dif-
ferentiation, immune factors, and ECM remodeling.
Genes of interest, including those with significant
changes, are listed in Table 1. Cardiac hypertrophy
markers confirmed that significant hypertrophy was in-
duced in TAC hearts, with a marked increase in the
early marker cMYC at days 2 and 7; the late markers
ANF and BNP were increased by day 7. In addition,
phospholamban (PLN), was down-regulated at day 7,
indicative of the initial stages of decompensated car-
diac hypertrophy.
As indicated by immunohistochemistry, vascular
growth was not induced until 2 days after TAC, as was
evident also from the gene expression analyses, with
few genes significantly different between TAC and
sham-surgery hearts. By day 7, however, TAC hearts
had more balanced angiogenic factors, confirmed by a
similar capillary density in TAC and sham-surgery
hearts. Although several positive angiogenic factors
were up-regulated, others were down-regulated, along
with an increased expression of the negative regulator
Serpinf1. The most apparent pattern of growth and
differentiation factors was a notable increase in both
processes at day 7. However, the localized growth
factor Ereg was highly expressed at day 2, indicating
that it may be the early growth-inducing factor,
whereas two main differentiation factors, Fzd5 and
Lect1, were down-regulated. In accord with previous
studies,35 we found a significant increase in many im-
mune factors early (day 2), but by day 7 these factors
were decreased, and their negative regulator, Tgfb2,
was increased. One of the more regulated processes
at both day 2 and 7 was ECM remodeling, with up-
regulated remodeling occurring by day 7. The balance
of factors at 2 days after TAC (Ctgf and Thbs1 up-
regulated; Lama5, MMP2, and MMP9 down-regulated)may contribute to their role in the angiogenic process
at this time point.
Discussion
Traditional dogma states that early ventricular remod-
eling in response to pathological stimuli is an adaptive
process, but that a later, maladaptive period follows.36
The changes that encompass cardiac remodeling
are well defined and include myocyte hypertrophy,
fibrosis, and vascular remodeling.37–39 Although each
factor has been targeted for therapeutic intervention,
studies have yielded conflicting results. For example,
attenuation of myocyte hypertrophy by propranolol
treatment improved cardiac function, despite no
change in collagen accumulation.40 The use of a cal-
cimimetic to treat cardiac hypertrophy and remodeling
induced by renal failure improved function by decreas-
ing fibrosis and increasing capillary density, whereas
left ventricular hypertrophy remained unchanged.41
Additional studies have identified the induction of an-
giogenesis as the main determinant of cardiac func-
tion, regardless of hypertrophy or fibrosis.11,42
It is likely that coordination of these events produces
the functional outcome, and here we demonstrate for
the first time the early interaction and coordination of
morphological changes, cell populations, and gene
expression after pathological cardiac insult. Overall
cardiac hypertrophy was significant 2 days after TAC
and peaked by day 7, and myocyte hypertrophy oc-
curred between days 2 and 7, thus defining the early
growth and remodeling phase. Within this phase, we
observed several morphological changes, including a
sudden increase in fibrosis, extensive vascular remod-
eling, as well as alterations in cell populations, prolif-
eration, and growth. The time course of the present
study allows these events to be correlated with one
another, providing valuable insight for future studies of
cardiac pathology.
Within 48 hours after induction of pressure overload,
the left ventricular free wall and septum significantly en-
Figure 6. Cell populations in the heart are al-
tered early in response to pressure overload.
Fluorescence-activated flow cytometry was used
to label and quantify cell populations of the
heart at 3, 7, and 14 days after TAC. Equal num-
bers of cells were analyzed in each group; for
percentage calculation, the absolute quantity of
cell type was divided by total cells within each
sample. *P  0.05 versus sham surgery and day
2 TAC; **P  0.05 versus all other groups. n  4.larged, reflected in an increase in heart weight and rela-
Early Morphological Changes in the Heart 1233
AJP October 2012, Vol. 181, No. 10tive wall thickness, compared with sham-surgery coun-
terparts. The ventricular hypertrophy at this time point
was not correlated with an increased fibroblast cell pop-
Table 1. Fold Changes in mRNA Gene Expression at 2 and 7 Da
Regulation of Process Gene
Day 2 TAC
surg
Angiogenesis
 Angpt1 2.6
 Efna1 2.6
 Flt1 1.2
 Hand2 1.0
 Hif1a 1.0
 Nrp2 1.3
 Pecam1 1.3
 Pgf 2.1
 Tek 1.2
 Vegfa 1.2
 Vegfb 1.1
 Vegfc 1.0
 Vegfd† 1.4
 VegfR2 1.8
 Angpt2 1.1
 Serpinf1 1.2
Growth and differentiation
 Egf 1.5
 Ereg 22.2
 Fgf1 1.5
 Fgf2 1.7
 Fgf6 1.0
 Fgfr3 1.1
 Hgf 3.9
 Igf1 1.6
 Mdk 3.0
 Tgfa 1.7
 Tgfb1 1.0
 Tgfbr1 1.2
 Fzd5 2.4
 Jag1 1.1
 Lect1 3.6
 Tgfb3 1.5
Immune function
 Ccl2 2.8
 Ccl11 3.2
 Cxcl1 1.4
 Cxcl2 26.8
 Cxcl5 99.8
 IL1b 27.2
 IL6 41.7
 Tnf 1.1
 Tgfb2 1.3
Extracellular matrix
 Col18a1 1.0
 Col4a3 2.0
 Ctgf 2.8
 Itgav 1.5
 Itgb3 1.5
 Lama5 2.1
 MMP19 1.2
 MMP2 1.5
 MMP9 3.8
 Thbs1 2.7
 Thbs2 2.0
 Timp2 1.0
 Tmprss6 2.2
Data are expressed as fold regulation up () or down ().
*P  0.05.
†Synonym for Figf (c-fos induced growth factor).
TAC, transverse aortic constriction surgery.ulation, ECM deposition, or myocyte hypertrophy, indicat-ing that an acute inflammatory response may account for
the immediate remodeling (as reflected in the increased
heart weight and wall thickness). This notion is supported
r Transverse Aortic Constriction Surgery or Sham Surgery
am Day 7 TAC vs sham
surgery
Day 7 TAC vs Day 2
TAC
2.255* 1.179
1.332 1.981
1.133 1.088
2.954 3.210*
3.536* 3.876*
1.794 2.462*
1.702 2.374*
2.696* 1.265
1.392 1.768*
1.552 1.195*
2.703* 2.286*
2.143* 2.315*
2.898* 4.083*
1.032 1.835*
1.329 1.580
7.462* 9.442*
1.312 1.153
7.499* 2.967
1.185 1.350
1.620* 2.808*
2.164 2.042
1.390 1.187
3.806 1.038
3.924* 6.382*
22.037* 7.257*
11.372* 19.809*
1.464* 1.594*
1.439 1.732
1.788* 4.430*
2.258* 2.684*
10.001* 2.774*
4.256* 2.797*
1.560 4.434*
4.032* 1.230
1.037 1.487
1.003 26.913*
1.481 67.403*
3.323 8.207*
107.776* 2.580
1.176 1.063
6.054* 4.347*
3.981* 3.663*
2.911* 6.015*
15.966* 5.594*
3.697* 5.573*
2.422 3.852*
1.123 1.934*
1.259 1.544
4.963* 7.845*
1.005 3.828*
17.838* 6.432*
4.608* 9.355*
1.711* 1.652*
4.490 10.017*ys afte
vs sh
ery
58
38*
33*
87
96
73
94
31
70
99
82
80
09
93*
89
65
12
50*
99*
33*
60
72
52
26
37
42
89
04
78*
89
05*
21
43*
79
34
22*
14*
74*
70*
06
93
87
66
54*
07
90
72*
26
81*
10*
73*
30
36
31by our gene expression data and by previous studies
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cells.35
In addition to hypertrophy, a significant decrease in
capillary density was observed 2 days after TAC, a
time point that was also marked by a significant reduc-
tion in the endothelial cell population (other popula-
tions remained constant). A decrease in vascular den-
sity at this time point may explain the observed
decrease in cardiac function, because previous stud-
ies have shown that an imbalance of capillary density
and hypertrophy causes cardiac dysfunction.11 A sig-
nificant increase in pericytes is associated with the
reduced capillary density, which may also be reflected
by a significant increase in the unlabeled cell popula-
tion in flow cytometry quantification. Previous research
suggests that pericytes are attempting to stabilize ves-
sels and minimize vascular remodeling at this point.30
Although a decrease in capillary density may appear to
be maladaptive, vessel regression is an early step in
angiogenesis, important for proper organization of
growing capillaries. The participation of pericytes
could mark the period in which degradation transitions
to new capillary formation and revascularization of the
tissue. Clearly, the critical events that define an imme-
diate response to cardiac hypertrophy include an in-
flammatory response and vascular regression regu-
lated by pericyte infiltration and altered endothelial cell
populations, with the fibroblast and ECM morphology
remaining relatively unchanged.
The ensuing remodeling process develops entirely
new morphological features within the myocardium,
reflected in the relative increase in gene expression
changes at day 7, compared with day 2. Although
development of fibrosis in response to pathology has
long been established,35,38 here we show that it occurs
rapidly between days 2 and 7 after induction of pres-
sure overload in mice and is accompanied by a signif-
icant increase in the cardiac fibroblast population. Pro-
liferation rates correlated with increased populations of
endothelial cells and fibroblasts, and we inferred that
resident cardiac cells readily proliferate and contribute
to the increased nonmyocyte cell populations ob-
served 7 days after TAC. However, given the timing
and transient nature of the pericyte population, it is
possible that these cells are recruited from the circu-
lation or are rapidly differentiated.
The combination of fibrosis and increase in nonmyo-
cyte cell populations, along with significant myocyte
hypertrophy, contributes to the increased heart weight
in TAC mice at day 7, compared with day 2 (Figure 7).
Given these results, future studies targeting patholog-
ical collagen deposition should focus on this early time
period. Indeed, recent studies confirm that fibroblast-
mediated changes do not appear until 1 week after
pathological stimulation,17 and here we have shown
that these changes take place concurrently with vas-
cular regrowth (because coronary capillary density in-
creased back to sham-surgery levels 7 days after
TAC). It is possible that, even though the expanding
fibroblast population deposits excess ECM (a mal-
adaptive process that stiffens the heart), it also simul-taneously stimulates capillary growth (an adaptive pro-
cess to deliver more oxygen and nutrients to the
expanding myocardium). Given this implication, and in
conjunction with the finding of unperturbed prolifera-
tive rates 7 days after TAC, regulation of fibroblasts
could offer an advantageous route of therapy. In par-
ticular, fibroblast turnover seems to be an interesting
therapeutic target, because p-histone H3 staining in-
dicates that resident fibroblasts (and other nonmyo-
cyte populations) are rapidly proliferating 7 days after
TAC but cell populations remain unchanged through
day 14, suggesting that rapid cell proliferation is re-
quired to replace cell populations (Figure 7). The de-
crease in nonmyocyte proliferation by day 28 may also
contribute to the transition into cardiac dysfunction,
because these populations may be unable to sustain
the appropriate levels of turnover and/or activity re-
quired to maintain ECM composition and vasculature.
Gene expression indicates that the processes of
angiogenesis, ECM remodeling, and cell growth are
activated concurrently. Separating the two processes
of ECM deposition and capillary formation at the early,
physiological time point may provide the groundwork
for a healthier, functional myocardium during late
stages of pathological remodeling. Although the TAC
model is an accurate system for portraying remodeling
events in the heart,43 the human response to pressure
overload (eg, during hypertension) is obviously more
gradual and may vary with respect to specific timing of
remodeling. Future studies should examine the remod-
eling events in a clinical setting. Nonetheless, our pres-
ent results provide a basis for investigating how these
events are coordinated during remodeling and point to
the importance of this analysis and possible interven-
tion before pathological remodeling appears.
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